Ines Koch

1.3k total citations
16 papers, 1.1k citations indexed

About

Ines Koch is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Ines Koch has authored 16 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Pharmacology. Recurrent topics in Ines Koch's work include Inflammatory mediators and NSAID effects (5 papers), Estrogen and related hormone effects (4 papers) and RNA Research and Splicing (3 papers). Ines Koch is often cited by papers focused on Inflammatory mediators and NSAID effects (5 papers), Estrogen and related hormone effects (4 papers) and RNA Research and Splicing (3 papers). Ines Koch collaborates with scholars based in Germany, United States and India. Ines Koch's co-authors include Carsten Denkert, Manfred Dietel, Wilko Weichert, Jalid Sehouli, Steffen Hauptmann, Silvia Niesporek, Aurelia Noske, Martin Köbel, Angela Reles and Sören Pest and has published in prestigious journals such as Cancer, Cancer Research and Oncogene.

In The Last Decade

Ines Koch

16 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ines Koch Germany	13	667	288	270	219	216	16	1.1k
Georgia Sotiropoulou‐Bonikou Greece	16	445 0.7×	210 0.7×	324 1.2×	109 0.5×	252 1.2×	36	973
Martina L. Skrede Norway	16	520 0.8×	247 0.9×	172 0.6×	38 0.2×	241 1.1×	22	1.0k
Sören Pest Germany	7	278 0.4×	141 0.5×	225 0.8×	280 1.3×	123 0.6×	8	646
Maria Grazia Prisco Italy	16	310 0.5×	117 0.4×	131 0.5×	50 0.2×	316 1.5×	22	761
Emily J. Faivre United States	13	613 0.9×	107 0.4×	578 2.1×	48 0.2×	421 1.9×	19	1.1k
Y Omoto Japan	14	488 0.7×	279 1.0×	550 2.0×	46 0.2×	400 1.9×	23	1.1k
Akira Morimiya United States	11	628 0.9×	343 1.2×	190 0.7×	108 0.5×	504 2.3×	16	1.1k
Toshiaki Utsumi Japan	16	383 0.6×	156 0.5×	671 2.5×	38 0.2×	351 1.6×	51	1.1k
Queeny K.Y. Chan Hong Kong	12	602 0.9×	179 0.6×	191 0.7×	20 0.1×	233 1.1×	12	960
Demetra Constantinidou United Kingdom	5	1.1k 1.6×	188 0.7×	444 1.6×	40 0.2×	495 2.3×	6	1.4k

Countries citing papers authored by Ines Koch

Since Specialization

Citations

This map shows the geographic impact of Ines Koch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ines Koch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ines Koch more than expected).

Fields of papers citing papers by Ines Koch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ines Koch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ines Koch. The network helps show where Ines Koch may publish in the future.

Co-authorship network of co-authors of Ines Koch

This figure shows the co-authorship network connecting the top 25 collaborators of Ines Koch. A scholar is included among the top collaborators of Ines Koch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ines Koch. Ines Koch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Dragomir, Mihnea P., Eilís Pérez, Simon Schallenberg, et al.. (2023). DNA methylation-based classifier differentiates intrahepatic pancreato-biliary tumours. EBioMedicine. 93. 104657–104657. 12 indexed citations

Jurmeister, Philipp, Inga Hoffmann, Claudia Vollbrecht, et al.. (2021). Mucosal melanomas of different anatomic sites share a common global DNA methylation profile with cutaneous melanoma but show location‐dependent patterns of genetic and epigenetic alterations. The Journal of Pathology. 256(1). 61–70. 20 indexed citations

Hoffmann, Inga, Claudia Vollbrecht, Ines Koch, et al.. (2021). Comparative investigation of cell cycle and immunomodulatory genes in mucosal and cutaneous melanomas: Preliminary data suggest a potential promising clinical role for p16 and the PD-1/PD-L1 axis. Pathology - Research and Practice. 229. 153689–153689. 2 indexed citations

Arsenić, Ruža, Annika Lehmann, Jan Budczies, et al.. (2013). Analysis of PIK3CA Mutations in Breast Cancer Subtypes. Applied immunohistochemistry & molecular morphology. 22(1). 50–56. 44 indexed citations

Koch, Ines, Alejandro Lomniczi, Alberto Loche, et al.. (2011). Transcription of the human EAP1 gene is regulated by upstream components of a puberty-controlling Tumor Suppressor Gene network. Molecular and Cellular Endocrinology. 351(2). 184–198. 15 indexed citations

Noske, Aurelia, Wilko Weichert, Silvia Niesporek, et al.. (2008). Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancer. Cancer. 112(8). 1733–1743. 177 indexed citations

Denkert, Carsten, Achilleas Thoma, Silvia Niesporek, et al.. (2007). Overexpression of cyclooxygenase‐2 in human prostate carcinoma and prostatic intraepithelial neoplasia‐association with increased expression of polo‐like kinase‐1. The Prostate. 67(4). 361–369. 19 indexed citations

Noske, Aurelia, Wilko Weichert, Christine Sers, et al.. (2006). Specific inhibition of AKT2 by RNA interference results in reduction of ovarian cancer cell proliferation: Increased expression of AKT in advanced ovarian cancer. Cancer Letters. 246(1-2). 190–200. 45 indexed citations

Denkert, Carsten, Ines Koch, Aurelia Noske, et al.. (2006). Expression of the ELAV-like protein HuR in human colon cancer: association with tumor stage and cyclooxygenase-2. Modern Pathology. 19(9). 1261–1269. 149 indexed citations

10.

Sun, Pengming, Jalid Sehouli, Carsten Denkert, et al.. (2005). Expression of estrogen receptor-related receptors, a subfamily of orphan nuclear receptors, as new tumor biomarkers in ovarian cancer cells. Journal of Molecular Medicine. 83(6). 457–467. 110 indexed citations

11.

Denkert, Carsten, Wilko Weichert, Sören Pest, et al.. (2004). Overexpression of the Embryonic-Lethal Abnormal Vision-like Protein HuR in Ovarian Carcinoma Is a Prognostic Factor and Is Associated with Increased Cyclooxygenase 2 Expression. Cancer Research. 64(1). 189–195. 142 indexed citations

12.

Denkert, Carsten, Antje Fürstenberg, Peter T. Daniel, et al.. (2003). Induction of G0/G1 cell cycle arrest in ovarian carcinoma cells by the anti-inflammatory drug NS-398, but not by COX-2-specific RNA interference. Oncogene. 22(54). 8653–8661. 83 indexed citations

13.

Denkert, Carsten, Ines Koch, Stefan Berger, et al.. (2003). Cytokine-suppressive anti-inflammatory drugs (CSAIDs) inhibit invasion and MMP-1 production of ovarian carcinoma cells. Cancer Letters. 195(1). 101–109. 16 indexed citations

14.

Hauptmann, Steffen, Carsten Denkert, Ines Koch, et al.. (2002). Genetic alterations in epithelial ovarian tumors analyzed by comparative genomic hybridization. Human Pathology. 33(6). 632–641. 54 indexed citations

15.

Denkert, Carsten, Martin Köbel, Sören Pest, et al.. (2002). Expression of Cyclooxygenase 2 Is an Independent Prognostic Factor in Human Ovarian Carcinoma. American Journal Of Pathology. 160(3). 893–903. 163 indexed citations

16.

Trapp, Stefan, Ines Koch, & Helle Christiansen. (2001). Aufnahme von Cyanid in Pflanzen. Umweltwissenschaften und Schadstoff-Forschung. 13(1). 20–28. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact